GUIDING CELLS TO IMPROVE LIFE Trademark

Trademark Overview

On Thursday, July 29, 2010, a trademark application was filed for GUIDING CELLS TO IMPROVE LIFE with the United States Patent and Trademark Office. The USPTO has given the GUIDING CELLS TO IMPROVE LIFE trademark a serial number of 85096318. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, May 11, 2023. This trademark is owned by Fate Therapeutics, Inc.. The GUIDING CELLS TO IMPROVE LIFE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

medical and clinical research and development for others in the field of stem cells; consulting services in the field of stem cell therapy research, disease model systems research, and drug discovery and development; medical laboratory research; research, namely, scientific research; medical and scientific research, namely, conducting pre-clinical and clinical trials
guiding cells to improve life

General Information

Serial Number85096318
Word MarkGUIDING CELLS TO IMPROVE LIFE
Filing DateThursday, July 29, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, May 11, 2023
Registration Number4143378
Registration DateTuesday, May 15, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2011

Trademark Statements

Goods and Servicesmedical and clinical research and development for others in the field of stem cells; consulting services in the field of stem cell therapy research, disease model systems research, and drug discovery and development; medical laboratory research; research, namely, scientific research; medical and scientific research, namely, conducting pre-clinical and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 3, 2010
Primary Code042
First Use Anywhere DateFriday, January 6, 2012
First Use In Commerce DateFriday, January 6, 2012

Trademark Owner History

Party NameFate Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameFate Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameFate Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Thursday, May 11, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, May 11, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, May 11, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, May 8, 2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, November 8, 2022POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Saturday, November 5, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 6, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, May 15, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, December 8, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, December 8, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, December 8, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 14, 2018TEAS SECTION 8 & 15 RECEIVED
Tuesday, May 16, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 15, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 15, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 15, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, April 10, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 9, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, April 9, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 2, 2012STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 8, 2012USE AMENDMENT FILED
Friday, March 30, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 8, 2012TEAS STATEMENT OF USE RECEIVED
Saturday, October 8, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 6, 2011SOU EXTENSION 1 GRANTED
Thursday, October 6, 2011SOU EXTENSION 1 FILED
Thursday, October 6, 2011TEAS EXTENSION RECEIVED
Tuesday, April 12, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 15, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2011PUBLISHED FOR OPPOSITION
Saturday, January 8, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 4, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 4, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, January 4, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 4, 2011EXAMINERS AMENDMENT E-MAILED
Tuesday, January 4, 2011EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 4, 2011PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, December 20, 2010WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, December 8, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 8, 2010ASSIGNED TO LIE
Tuesday, November 16, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 12, 2010ASSIGNED TO EXAMINER
Tuesday, August 3, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 2, 2010NEW APPLICATION ENTERED

Related Keywords

life improve cells guiding research medical clinical namely scientific stem development field drug discovery